Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Géraldine Buhagiar

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Cell Cycle (Georgetown, Tex.)|May 3, 2017
Cytidine deaminase deficiency impairs sister chromatid disjunction by decreasing PARP-1 activitySimon Gemble, Géraldine Buhagiar-Labarchède, Rosine Onclercq-Delic, et al.
Journal of Nucleic Acids|October 12, 2010
BLM Deficiency Is Not Associated with Sensitivity to Hydroxyurea-Induced Replication StressKenza Lahkim Bennani-Belhaj, Géraldine Buhagiar-Labarchède, Nada Jmari, et al.
Open Biology|May 14, 2020
Topoisomerase IIα prevents ultrafine anaphase bridges by two mechanismsSimon Gemble, Géraldine Buhagiar-Labarchède, Rosine Onclercq-Delic, et al.
Journal of Cell Science|July 8, 2016
A balanced pyrimidine pool is required for optimal Chk1 activation to prevent ultrafine anaphase bridge formationSimon Gemble, Géraldine Buhagiar-Labarchède, Rosine Onclercq-Delic, et al.
Nature Communications|June 30, 2011
Pyrimidine pool imbalance induced by BLM helicase deficiency contributes to genetic instability in Bloom syndromePauline Chabosseau, Géraldine Buhagiar-Labarchède, Rosine Onclercq-Delic, et al.
Scientific Reports|August 18, 2022
Cytidine deaminase activity increases in the blood of breast cancer patientsGéraldine Buhagiar-Labarchède, Rosine Onclercq-Delic, Sophie Vacher, et al.
Cancer Letters|December 10, 2022
Cytidine deaminase deficiency in mice enhances genetic instability but limits the number of chemically induced colon tumorsRosine Onclercq-Delic, Géraldine Buhagiar-Labarchède, Sophie Leboucher, et al.
Nucleic Acids Research|August 20, 2024
A CRISPR-dCas13 RNA-editing tool to study alternative splicingYaiza Núñez-Álvarez, Tristan Espie-Caullet, Géraldine Buhagiar, et al.
Cellular and Molecular Life Sciences : CMLS|August 4, 2022
Cytidine deaminase deficiency in tumor cells is associated with sensitivity to a naphthol derivative and a decrease in oncometabolite levelsHamza Mameri, Géraldine Buhagiar-Labarchède, Gaëlle Fontaine, et al.
Molecular Cancer Research : MCR|March 11, 2010
The Bloom syndrome protein limits the lethality associated with RAD51 deficiencyKenza Lahkim Bennani-Belhaj, Sébastien Rouzeau, Géraldine Buhagiar-Labarchède, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cell Cycle (Georgetown, Tex.)|May 3, 2017
Cytidine deaminase deficiency impairs sister chromatid disjunction by decreasing PARP-1 activitySimon Gemble, Géraldine Buhagiar-Labarchède, Rosine Onclercq-Delic, et al.
Journal of Nucleic Acids|October 12, 2010
BLM Deficiency Is Not Associated with Sensitivity to Hydroxyurea-Induced Replication StressKenza Lahkim Bennani-Belhaj, Géraldine Buhagiar-Labarchède, Nada Jmari, et al.
Open Biology|May 14, 2020
Topoisomerase IIα prevents ultrafine anaphase bridges by two mechanismsSimon Gemble, Géraldine Buhagiar-Labarchède, Rosine Onclercq-Delic, et al.
Journal of Cell Science|July 8, 2016
A balanced pyrimidine pool is required for optimal Chk1 activation to prevent ultrafine anaphase bridge formationSimon Gemble, Géraldine Buhagiar-Labarchède, Rosine Onclercq-Delic, et al.
Nature Communications|June 30, 2011
Pyrimidine pool imbalance induced by BLM helicase deficiency contributes to genetic instability in Bloom syndromePauline Chabosseau, Géraldine Buhagiar-Labarchède, Rosine Onclercq-Delic, et al.
Scientific Reports|August 18, 2022
Cytidine deaminase activity increases in the blood of breast cancer patientsGéraldine Buhagiar-Labarchède, Rosine Onclercq-Delic, Sophie Vacher, et al.
Cancer Letters|December 10, 2022
Cytidine deaminase deficiency in mice enhances genetic instability but limits the number of chemically induced colon tumorsRosine Onclercq-Delic, Géraldine Buhagiar-Labarchède, Sophie Leboucher, et al.
Nucleic Acids Research|August 20, 2024
A CRISPR-dCas13 RNA-editing tool to study alternative splicingYaiza Núñez-Álvarez, Tristan Espie-Caullet, Géraldine Buhagiar, et al.
Cellular and Molecular Life Sciences : CMLS|August 4, 2022
Cytidine deaminase deficiency in tumor cells is associated with sensitivity to a naphthol derivative and a decrease in oncometabolite levelsHamza Mameri, Géraldine Buhagiar-Labarchède, Gaëlle Fontaine, et al.
Molecular Cancer Research : MCR|March 11, 2010
The Bloom syndrome protein limits the lethality associated with RAD51 deficiencyKenza Lahkim Bennani-Belhaj, Sébastien Rouzeau, Géraldine Buhagiar-Labarchède, et al.
Pageof 2